Tumor Necrosis Rate Adjusted by Tumor Volume Change Is a Better Predictor of Survival of Localized Osteosarcoma Patients
Authors:
- 28 December 2007
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 15 (3) , 906-914
Abstract
We assessed whether new parameter that considers both tumor volume change and necrosis rate predicts metastasis-free survival of localized osteosarcoma patients. We also evaluated relationship between tumor volume change and necrosis rate or metastasis-free survival. We retrospectively reviewed 151 patients with stage II osteosarcoma who were treated with surgery and neoadjuvant chemotherapy. The tumor volume change was measured and calculated based on pre- and postchemotherapy magnetic resonance images. The mean metastasis-free interval was 83.1 months. We calculated adjusted tumor necrosis rate as following formula: 100–(100–necrosis rate) × postchemotherapy/prechemotherapy tumor volume. Survival and logistic regression analyses were used to evaluate the correlation among size parameters, tumor necrosis rate and survival. The 5-year metastasis-free survival rate of 151 patients was 71.4% (95% CI, 67.7–75.1%). American Joint Committee on Cancer (AJCC) stage IIB (RR 2.27; 95% CI, 1.11–4.62; P = 0.025) and poor adjusted tumor necrosis rate (RR 2.02; 95% CI, 1.05–3.89; P = 0.035) independently correlated with metastasis-free survival period. Further, tumor volume change independently correlated with necrosis rate. Decreased tumor volume could predict good response, with sensitivity of 80.2%, specificity of 68.6%, and positive predictive value (PPV) of 74.7%. Increased or stable tumor volume could predict poor response, with sensitivity of 68.6%, specificity of 80.2%, and PPV of 75.0 %. The necrosis rate adjusted by the tumor volume change is an independent prognostic factor in osteosarcoma. This adjusted tumor necrosis rate may serve as a basis for risk-adapted therapy in combination with other prognostic factors.Keywords
This publication has 29 references indexed in Scilit:
- Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institutionEuropean Journal of Cancer, 2005
- Tumor Volume Change after Chemotheraphy as a Predictive Factor of Disease Free Survival for OsteosarcomaYonsei Medical Journal, 2005
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Use of99mTc-MIBI scintigraphy in the evaluation of the response of osteosarcoma to chemotherapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997
- Treatment of high-grade bone sarcomas with neoadjuvant chemotherapy: the utility of sequential color Doppler sonography in predicting histopathologic response.American Journal of Roentgenology, 1995
- Can MRI predict the histopathological response in patients with osteosarcoma after the first cycle of chemotherapy?Clinical Radiology, 1995
- The value of computed tomographic measurements in Osteosarcoma as a Predictor of Response to Adjuvant chemotherapyClinical Radiology, 1994
- Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experienceCancer, 1992
- The value of MR imaging in monitoring the effect of chemotherapy on bone sarcomas.American Journal of Roentgenology, 1990
- Prognostic Variables in Osteosarcoma: A Multi-Institutional StudyJNCI: Journal of the National Cancer Institute, 1989